ArticleMultiple sclerosis (Houndmills, Basingstoke, England)2019

Safety and efficacy of helminth treatment in relapsing-remitting multiple sclerosis: Results of the HINT 2 clinical trial.

John Fleming et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.